These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36064627)

  • 21. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
    Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
    Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
    Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
    Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD
    Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
    Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
    Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids.
    Sommer MJ; Halter S; Angerer V; Auwärter V; Eyer F; Liebetrau G; Ebbecke M; Hermanns-Clausen M
    Clin Toxicol (Phila); 2022 Oct; 60(10):1130-1138. PubMed ID: 36074033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists.
    Deventer MH; Van Uytfanghe K; Vinckier IMJ; Reniero F; Guillou C; Stove CP
    Drug Test Anal; 2022 Sep; 14(9):1565-1575. PubMed ID: 35560866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of synthetic cannabinoids in wastewater of major cities in China.
    Fan X; Zhang J; Fu X; Zhou B; Xu Z; Huang H; Han S; Li X
    Sci Total Environ; 2022 Jun; 827():154267. PubMed ID: 35247413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of third generation synthetic cannabinoids using zebrafish larvae.
    Morales-Noé A; Esteve-Turrillas FA; Armenta S
    Drug Test Anal; 2022 Apr; 14(4):594-603. PubMed ID: 34750997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Spice"-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoid receptor agonists in our post-mortem cases over a seven-year period (2014-2020).
    Groth O; Roider G; Angerer V; Schäper J; Graw M; Musshoff F; Auwärter V
    Int J Legal Med; 2023 Jul; 137(4):1059-1069. PubMed ID: 37072496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services.
    Oomen PE; Schori D; Tögel-Lins K; Acreman D; Chenorhokian S; Luf A; Karden A; Paulos C; Fornero E; Gerace E; Koning RPJ; Galindo L; Smit-Rigter LA; Measham F; Ventura M
    Int J Drug Policy; 2022 Feb; 100():103493. PubMed ID: 34687992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
    Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL
    Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and quantification of synthetic cannabinoid receptor agonists in human urine using membrane-assisted solvent extraction followed by liquid chromatography-tandem mass spectrometry.
    Suárez-Oubiña C; Álvarez-Freire I; Cabarcos P; Bermejo AM; Bermejo-Barrera P; Moreda-Piñeiro A
    Anal Methods; 2023 Jan; 15(3):333-342. PubMed ID: 36594640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
    Niebel A; Pragst F; Krumbiegel F; Hartwig S
    Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    Drug Test Anal; 2018 Apr; 10(4):644-650. PubMed ID: 28967189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches.
    Vaccaro G; Massariol A; Guirguis A; Kirton SB; Stair JL
    Drug Test Anal; 2022 Aug; 14(8):1350-1367. PubMed ID: 35355411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids.
    Protti M; Rudge J; Sberna AE; Gerra G; Mercolini L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():77-86. PubMed ID: 28088044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
    Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
    Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.